Abstract
An efficient synthesis of the selective H4 receptor agonist 4-methylhistamine is described. This approach can be used to prepare, without purification steps and in high yield, significant quantities of the product, useful as pharmacological tool to investigate the physiological roles of the histamine H4 receptor.
Keywords: 4-methylhistamine, histamine, H4-receptor, n-butyllithium, H4-agonist, yield
Letters in Organic Chemistry
Title: A Short and Efficient Synthesis of the Selective H4 Receptor Agonist 4- Methylhistamine
Volume: 6 Issue: 1
Author(s): Mirko Rivara, Valentina Zuliani, Pier V. Plazzi and Fabrizio Bordi
Affiliation:
Keywords: 4-methylhistamine, histamine, H4-receptor, n-butyllithium, H4-agonist, yield
Abstract: An efficient synthesis of the selective H4 receptor agonist 4-methylhistamine is described. This approach can be used to prepare, without purification steps and in high yield, significant quantities of the product, useful as pharmacological tool to investigate the physiological roles of the histamine H4 receptor.
Export Options
About this article
Cite this article as:
Rivara Mirko, Zuliani Valentina, Plazzi V. Pier and Bordi Fabrizio, A Short and Efficient Synthesis of the Selective H4 Receptor Agonist 4- Methylhistamine, Letters in Organic Chemistry 2009; 6 (1) . https://dx.doi.org/10.2174/157017809787003223
DOI https://dx.doi.org/10.2174/157017809787003223 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Targets of Antidementive Therapy: Drugs with a Specific Pharmacological Mechanism of Action
Current Pharmaceutical Design Patent Selections:
Recent Patents on CNS Drug Discovery (Discontinued) Chromatin Remodelling: Distinct Molecular Events During Differentiation and Activation of T Cells
Current Immunology Reviews (Discontinued) Possible Role of the Extracellular Signal-Regulated Kinase (ERK) in Reward-Controlled Learning and Addiction
Current Neuropharmacology Vascular Endothelial Cell Growth Factor (VEGF), An Emerging Target for Cancer Chemotherapy
Current Medicinal Chemistry - Anti-Cancer Agents Down-regulation of MiR-138-5p Protects Chondrocytes ATDC5 and CHON-001 from IL-1 β-induced Inflammation <I>Via</I> Up-regulating SOX9
Current Pharmaceutical Design Imidazoline Receptor Agonists in Obesity-Related Hypertension: Therapeutic Targeting of the Sympathetic Nervous System
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Improving Cognitive Outcome in Cerebral Malaria: Insights from Clinical and Experimental Research
Central Nervous System Agents in Medicinal Chemistry Nanostructured Modulators of Neuroglia
Current Pharmaceutical Design NADPH Oxidases in the Heart
Current Cardiology Reviews MicroRNAs: Biomarkers for Cardiovascular Disease in Patients with Diabetes Mellitus
Current Topics in Medicinal Chemistry Conventional and Novel Approaches in Generating and Characterization of Reactive Intermediates from Drugs/Drug Candidates
Current Drug Metabolism Green Biofactories: Recombinant Protein Production in Plants
Recent Patents on Biotechnology Obesity and Heart Failure
Endocrine, Metabolic & Immune Disorders - Drug Targets Biological Relevance of Lysophospholipids and Green Solutions for Their Synthesis
Current Organic Chemistry Erratum
Current Pharmaceutical Design Editorial (Thematic Issue: Targeting Cell Death and Proliferation Receptors in Cancer)
Current Pharmaceutical Design Progress Toward Understanding the Nature and Function of C-H...O Interactions
Current Organic Chemistry Some Recent Approaches of Biologically Active Substituted Pyridazine and Phthalazine Drugs
Current Medicinal Chemistry Adenoviral Vectors for Cancer Gene Therapy
Current Genomics